In summary, our data suggest that a single amino acid substitution between hAQP4 and mAQP4 is one possible reason why it will be challenging to establish an animal model of NMO in HLA-DRB1*03:01 transgenic mice. The gene discussed is AQP4; the disease is neuromyelitis optica.